The Scientist

» pharmaceuticals and immunology

Most Recent

image: Frisky Fruit Flies

Frisky Fruit Flies

By | November 5, 2013

Researchers show that Drosophila females upregulate an immune gene for protection against sexually transmitted infections before copulation.

1 Comment

image: It’s in the Genes

It’s in the Genes

By | October 24, 2013

Researchers find strong correlations between the composition of the human microbiome and genetic variation in immune-related pathways.

4 Comments

image: Company Size Won’t Predict Success

Company Size Won’t Predict Success

By | October 23, 2013

New analysis finds that the size of a company is not tied to getting a drug to market.

0 Comments

image: Drug Widens Immunity to Flu

Drug Widens Immunity to Flu

By | October 20, 2013

An immune suppressive drug can unexpectedly help immunized mice fight off many strains of flu.

0 Comments

image: Clinical Silence

Clinical Silence

By | October 10, 2013

A study has shown that less than half of the outcomes of some clinical trials are publicly available.

0 Comments

image: Criminal Hype

Criminal Hype

By | September 25, 2013

Overstating the benefits of a drug lands a former biotech executive in home detention.

0 Comments

image: Opinion: Reasons for the R&D Crisis

Opinion: Reasons for the R&D Crisis

By | September 23, 2013

Response to an opinion in The Scientist charting current pitfalls in translational research

2 Comments

image: Pharma Moves Toward Transparency

Pharma Moves Toward Transparency

By | July 29, 2013

The pharmaceutical industry has agreed to share data from clinical trials with researchers, patients, and the public.

0 Comments

image: Week in Review, July 8–12

Week in Review, July 8–12

By | July 12, 2013

Editor accused of fraud leaves post; the good and the bad of gut microbiota; bacterial gene shuffle; legal restrictions hamper illicit drug research; antibodies and autism

0 Comments

image: Misconduct Delayed Drug Approval

Misconduct Delayed Drug Approval

By | July 10, 2013

FDA endorsement of a new blood-thinning drug was held back for almost a year because the agency discovered misconduct at clinical trial sites in China.  

2 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
New England BioLabs
New England BioLabs
Advertisement
NeuroScientistNews
NeuroScientistNews
Life Technologies